Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Amneal Pharmaceuticals with status Current. The shortage was first posted on 07/14/2023.
Shortage Details
- Status
- Current
- Company
- Amneal Pharmaceuticals
- Package NDC
- 65162-028-09
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09)
- Initial Posting
- 07/14/2023
- Revised Date